Akero Therapeutics, Inc. Accounts Payable
Akero Therapeutics, Inc. had Accounts Payable of $20.40 million as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-11-07
- 2025-09-30: Accounts Payable, Current $20.40M.
- 2025-06-30: Accounts Payable, Current $13.25M.
- 2025-03-31: Accounts Payable, Current $10.83M.
- 2024-12-31: Accounts Payable, Current $9.03M.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-09-30 | $20.40M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $13.25M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $10.83M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $9.03M 10-Q · filed 2025-11-07 |
| 2024-09-30 | $25.22M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $14.57M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $13.78M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $7.04M 10-K · filed 2025-02-28 |
| 2023-09-30 | $11.45M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $10.12M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $7.08M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $7.97M 10-K · filed 2024-02-29 |
| 2022-09-30 | $6.01M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $6.88M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $4.45M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $6.71M 10-K · filed 2023-03-17 |
| 2021-09-30 | $6.78M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $2.31M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $4.61M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $3.43M 10-K · filed 2022-02-25 |
| 2020-09-30 | $4.64M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.54M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $1.53M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $947.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $93.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $3.25M 10-Q · filed 2019-08-12 |
| 2018-12-31 | $1.37M 10-K · filed 2020-03-16 |